Correction: the signal pathways and treatment of cytokine storm in COVID-19

L Yang, X Xie, Z Tu, J Fu, D Xu, Y Zhou - Signal transduction and …, 2021 - nature.com
After online publication of the article, 1 the editor noticed that Figs. 1 and 4 were produced
with the assistance of Servier Medical Art (https://smart. servier. com) without citation. The …

COVID‐19: Consider IL‐6 receptor antagonist for the therapy of cytokine storm syndrome in SARS‐CoV‐2 infected patients

C Chakraborty, AR Sharma… - Journal of medical …, 2020 - Wiley Online Library
COVID‐19 leads to mortality of several patients and the cytokine storm is reportedly critical
in the patients. To reduce the cytokine storm, we would like to propose the interleukin (IL) 6 …

Dynamic interleukin-6 level changes as a prognostic indicator in patients with COVID-19

Z Liu, J Li, D Chen, R Gao, W Zeng, S Chen… - Frontiers in …, 2020 - frontiersin.org
Background Interleukin-6 (IL-6), a proinflammatory cytokine, has been reported to be
associated with disease severity and mortality in patients with coronavirus disease 2019 …

[HTML][HTML] Influence of IL-6 levels on patient survival in COVID-19

N Arulkumaran, TAC Snow, A Kulkarni… - Journal of Critical …, 2021 - ncbi.nlm.nih.gov
COVID-19 is characterized by a proinflammatory phenotype, with an underlying cytokine
storm thought to be key in determining disease severity. Levels of the proinflammatory …

Preventing mortality in COVID-19 patients: which cytokine to target in a raging storm?

L Lu, H Zhang, M Zhan, J Jiang, H Yin… - Frontiers in cell and …, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19) from severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection has resulted in tremendous morbidity and mortality worldwide. A …

IL-6 and other biomarkers as predictors of severity in COVID-19

N Broman, K Rantasärkkä, T Feuth, M Valtonen… - Annals of …, 2021 - Taylor & Francis
Objective Cytokine release syndrome is suggested to be the most important mechanism
triggering acute respiratory distress syndrome and end organ damage in COVID-19. The …

Clinical characteristics and risk factors for disease severity and death in patients with coronavirus disease 2019 in Wuhan, China

L Zou, L Dai, Y Zhang, W Fu, Y Gao, Z Zhang… - Frontiers in …, 2020 - frontiersin.org
Objective: To describe the clinical manifestations and outcomes of COVID-19, and explore
the risk factors of deterioration and death of the disease. Methods: In this retrospective study …

Comparative survival analysis of immunomodulatory therapy for coronavirus disease 2019 cytokine storm

S Narain, DG Stefanov, AS Chau, AG Weber, G Marder… - Chest, 2021 - Elsevier
Background Cytokine storm is a marker of coronavirus disease 2019 (COVID-19) illness
severity and increased mortality. Immunomodulatory treatments have been repurposed to …

Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome

Y Yang, C Shen, J Li, J Yuan, M Yang, F Wang, G Li… - MedRxiv, 2020 - medrxiv.org
The outbreak of Coronavirus Disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, December 2019 …

Laboratory abnormalities and risk factors associated with in‐hospital death in patients with severe COVID‐19

X Chen, L Yan, Y Fei, C Zhang - Journal of Clinical Laboratory …, 2020 - Wiley Online Library
Background In the context of the COVID‐19 outbreak of worldwide, we aim to analyze the
laboratory risk factors of in‐hospital death in patients with severe COVID‐19. Methods All≥ …